Table 1.

Patient characteristics

WT1 peptide–specific DTH
A*02:01A*24:02DRB1/DPB1
HLA genotypeVaccine timesVaccine timesVaccine times
PatientSexAge, yUICC stageLocationMetastasesPrior systemic treatmentHLA-ADRB1DPB1VaccineTimes024680246802468
PDA-01M41IVPDA (body–tail)Bone, LNNo02:0108:0312:0102:0215:01DC/WT1-I19
PDA-02M69IVPDA (body–tail)Lung, peritonitis, LNNo24:0226:0112:0115:0205:0109:01DC/WT1-I11
PDA-03M73IVPDA (head)PeritonitisNo26:0333:0308:0208:0302:0205:01DC/WT1-II13
ICC-01F58IVICCPeritonitis, LNNo02:0124:0204:0515:0209:01DC/WT1-I15+++++++++++
PDA-04M70IVPDA (body)PeritonitisNo02:0124:0204:0515:0205:0109:01DC/WT1-I/II35+++++++++++++++++++++
PDA-05M68IVPDA (body)Liver, LNOpe, Cx24:0233:0308:0313:0202:0204:01DC/WT1-I/II46++++++++++++++
PDA-06F49IVPDA (head)Liver, peritonitis, LNNo02:0124:0204:0509:0102:0205:01DC/WT1-I/II7N.D.N.D.N.D.
PDA-07M35IVPDA (body)Liver, LNNo02:0109:0115:0102:0105:01DC/WT1-I/II6N.D.N.D.N.D.
PDA-08F72IVPDA (body)Peritonitis, LNNo02:0624:0208:0212:0102:0105:01DC/WT1-I/II14
PDA-09F69IVPDA (body–tail)LNNo24:0233:0313:0215:0104:0113:01DC/WT1-I/II44+++++++++++++++
PDA-10M39IVPDA (head–body)PeritonitisOpe02:1024:0215:0115:0202:0209:01DC/WT1-I/II20++++++

Abbreviations: Cx, chemotherapy; DTH -, erythema <1 mm; DTH +, erythema 2- 5 mm; DTH ++, erythema > 5 mm; LN, lymph nodes; N.D., not done; Ope, operation.